BSE filing, NSE: ANSINDUS. Summary written from the filing by ALFA Finder's alert engine.
ANS Industries Ltd: key numbers
- Share price
- ₹26.61
- Market cap
- ₹24.63 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹2.28 Cr
- P/E (TTM)
- 17.0×Sector 26.2×
- Promoter holding
- 53.10%+0.11% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from ANS Industries Ltd
All →ANS Industries Other Announcement
ANS Industries Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI LODR Regulations.
ANS Industries Annual General Meeting
ANS Industries Ltd. held its 32nd Annual General Meeting on September 30, 2026, where members considered financial statements and the re-appointment of a director.
ANS Industries Other Announcement
Under Reg 36(1)(b), ANS Industries shared a web-link and QR code of the FY 2025-26 Annual Report. It urged physical holders to update PAN, KYC, bank details.
ANS Industries Annual General Meeting
ANS Industries Ltd has issued a notice for its 32nd Annual General Meeting scheduled for September 30, 2026. Shareholders can participate via remote e-voting.
ANS Industries Annual General Meeting
ANS Industries Ltd. has scheduled its 32nd Annual General Meeting for September 30, 2026, at its registered office. The company will facilitate e-voting via NSDL.
ANS Industries Q1 FY27 Results: Net Loss of ₹1 Cr, Loss Widens
ANS Industries Ltd reported a net loss of ₹1 Cr for Q1 FY27.
- Key figure
- Net loss ₹1 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.